These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Mitomycin C and bleomycin in the treatment of far-advanced cervical cancer: a Southwest Oncology Group pilot study.
    Author: Leichman LP, Baker LH, Stanhope CR, Samson MK, Fraile RJ, Vaitkevicius VK, Hilgers R.
    Journal: Cancer Treat Rep; 1980; 64(10-11):1139-40. PubMed ID: 6161699.
    Abstract:
    Under the auspices of the Southwest Oncology Group, Wayne State University tested a schedule using bleomycin and mitomycin C that was previously reported to give a response rate of 88%. In our patients the same regimen produced similar toxic effects but a far different response rate of 15.8% (one complete remission and two partial remissions). The only discernible difference in the two patient groups was the amount of radiation given prior to chemotherapy.
    [Abstract] [Full Text] [Related] [New Search]